| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/07/2001 | EP1079825A2 Compounds that inhibit the binding of integrins to their receptors |
| 03/07/2001 | EP1079821A1 Protease inhibitors |
| 03/07/2001 | EP1079817A1 Pharmaceutical composition comprising d-chiro-inositol for improving insulin sensitivity and glucose metabolism |
| 03/07/2001 | EP1079811A1 Biodegradable sustained-release alginate gels |
| 03/07/2001 | EP0934295B1 Novel bi-aromatic dibenzofuran derivatives and their use in human and veterinary medicine and in cosmetics |
| 03/07/2001 | EP0839132B1 Novel process for the production of amorphous [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) |
| 03/07/2001 | EP0783505B1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE |
| 03/07/2001 | CN1286258A Purine L-nucleoside, analogs and use thereof |
| 03/07/2001 | CN1286088A Instant aminoacid-calcium particles and preparing process thereof |
| 03/07/2001 | CN1286066A Cooker with cooking function and method for preparing red ginseng extract using it |
| 03/07/2001 | CN1062859C Substd 1-naphthoyl guanidines, their preparing method, use and drug contg. them |
| 03/07/2001 | CN1062755C Health-care tea for preventing cardiovascular and cerebrovascular diseases and its preparing method |
| 03/07/2001 | CN1062751C Compound Chinese and western medicinal composition for treating diabets of kidney type |
| 03/07/2001 | CN1062749C Medicine for treating hyperlipemia and its preparing process |
| 03/07/2001 | CN1062742C Method for preparing pantocrine injection |
| 03/06/2001 | US6197982 Vitamin D analogues |
| 03/06/2001 | US6197972 Chemical intermediates for anticholesterol agents |
| 03/06/2001 | US6197930 Polypeptide for use in organ preservation, cryopreservation, for surgical pretreatment to prevent injury due to inflammation; antiischemic agents |
| 03/06/2001 | US6197926 Protein segments for prevention of preferential pancreas defect |
| 03/06/2001 | US6197822 Neuropeptide antagonists |
| 03/06/2001 | US6197815 Animal feed additive by preparing metal amino acid chelates, increasing desired metal uptake by the animal, and concomitant growth facilitation and enhancement for the treated animals. |
| 03/06/2001 | US6197813 At least one aldonic compound, a water-soluble zinc salt. |
| 03/06/2001 | US6197810 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides |
| 03/06/2001 | US6197794 Antiinflamamtory agents; immunology diseases |
| 03/06/2001 | US6197789 Antidiabetic agents |
| 03/06/2001 | US6197786 Anticholesterol agents |
| 03/06/2001 | US6197785 Cardiovascular disorders |
| 03/06/2001 | US6197780 Administering an endothelin anatgonist |
| 03/06/2001 | US6197773 N-acyl and N-aroyl aralkyl amides as serotonergic agents |
| 03/06/2001 | US6197759 Osteoblast-specific mitogens and drugs containing such compounds |
| 03/06/2001 | US6197758 Methods for supplying postgastrectomic mineral and methods for treating postgastrectomic syndrome |
| 03/06/2001 | US6197580 Transcriptional regulation of the human β3-adrenergic receptor gene |
| 03/06/2001 | US6197530 GPR10 as a target for identifying weight modulating compounds |
| 03/06/2001 | US6197340 Controlled release lipoic acid |
| 03/06/2001 | US6197294 Cells containing recombinant polynucleotides coding for cell surface molecules that, when expressed in the cell, result in rejection of the cell by host cell by host immune system; useful for gene therapy |
| 03/06/2001 | US6197290 Anion exchange resin-containing tablets |
| 03/06/2001 | US6197069 Adrenomedullin receptor polynucleotides |
| 03/06/2001 | CA2081113C Thiazolidine-2,4-dione derivative, salt thereof, and production of the same |
| 03/01/2001 | WO2001014557A1 Pd-1, a receptor for b7-4, and uses therefor |
| 03/01/2001 | WO2001014548A2 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | WO2001014414A2 Human abc2 transporter and uses thereof |
| 03/01/2001 | WO2001014386A1 Novel isoindole derivatives |
| 03/01/2001 | WO2001014371A1 N-heterocyclic derivatives as nos inhibitors |
| 03/01/2001 | WO2001014355A1 Substituted piperazine derivatives, the production thereof and their utilization as medicaments |
| 03/01/2001 | WO2001014352A1 Substituted benzylthiazolidine-2,4-dione derivatives |
| 03/01/2001 | WO2001014351A1 Substituted benzylthiazolidine-2,4-dione derivatives |
| 03/01/2001 | WO2001014350A1 Substituted benzylthiazolidine-2,4-dione derivatives |
| 03/01/2001 | WO2001014349A1 Substituted benzylthiazolidine-2,4-dione derivatives |
| 03/01/2001 | WO2001014333A1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 03/01/2001 | WO2001014318A2 New effectors of dipeptidyl peptidase iv for topical use |
| 03/01/2001 | WO2001013957A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 03/01/2001 | WO2001013935A2 Modulation of the blood-brain barrier transporter for leptin |
| 03/01/2001 | WO2001013934A1 Peptide and peptide analogues for the treatment and prevention of diabetes |
| 03/01/2001 | WO2001013917A1 Npy antagonists: spiroisoquinolinone derivatives |
| 03/01/2001 | WO2001013905A2 Methods for the treatment of mental and vascular disorders |
| 03/01/2001 | WO2001013901A2 A pharmaceutical delivery system for vitamin c and vitamin e and use of a combination of vitamin c and e for preventing or treating conditions involving oxidative stress |
| 03/01/2001 | WO2001013734A1 A natural tea for curing men's impotence and a method for manufacturing the same |
| 03/01/2001 | WO2001013716A1 α-TOCOPHEROL TRANSPORT PROTEIN KNOCKOUT ANIMAL |
| 03/01/2001 | WO2000073449B1 Dna encoding snorf33 receptor |
| 03/01/2001 | WO2000072885A9 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 03/01/2001 | WO2000068209A3 1,5-benzodiazepine derivatives as cck-a receptor agonists |
| 03/01/2001 | WO1998029107A3 Poly(diallylamine)-based bile acid sequestrants |
| 03/01/2001 | DE19941186A1 Sequenz-spezifische DNA-Rekombination in eukaryotischen Zellen Sequence-specific DNA recombination in eukaryotic cells |
| 03/01/2001 | DE19940130A1 Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung New effectors of dipeptidyl peptidase IV for topical use |
| 03/01/2001 | DE10036854A1 Neue kristalline Form von 6-Hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b] thiophenhydrochlorid New crystalline form of 6-hydroxy-3- (4- [2- (piperidin-1-yl) ethoxy] phenoxy) -2- (4-methoxyphenyl) benzo [b] thiophene hydrochloride |
| 03/01/2001 | CA2383456A1 Pd-1, a receptor for b7-4, and uses therefor |
| 03/01/2001 | CA2383063A1 Human abc2 transporter and uses thereof |
| 03/01/2001 | CA2382666A1 Modulation of the blood-brain barrier transporter for leptin |
| 03/01/2001 | CA2382582A1 Substituted benzylthiazolidine-2,4-dione derivatives |
| 03/01/2001 | CA2382574A1 Substituted benzylthiazolidine-2,4-dione derivatives |
| 03/01/2001 | CA2382528A1 Novel isoindole derivatives |
| 03/01/2001 | CA2382311A1 Substituted piperazine derivatives, the preparation thereof and their use as medicaments |
| 03/01/2001 | CA2382183A1 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | CA2381425A1 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 03/01/2001 | CA2381111A1 Npy antagonists: spiroisoquinolinone derivatives |
| 03/01/2001 | CA2380513A1 Methods for treatment of mental disorders |
| 03/01/2001 | CA2379875A1 New effectors of dipeptidyl peptidase iv for topical use |
| 03/01/2001 | CA2376250A1 Peptide and peptide analogues for the treatment and prevention of diabetes |
| 02/28/2001 | EP1078925A1 4-Phenylpiperidine compounds |
| 02/28/2001 | EP1078633A2 Compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 02/28/2001 | EP1078632A1 Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity |
| 02/28/2001 | EP1077994A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same |
| 02/28/2001 | EP1077971A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS |
| 02/28/2001 | EP1077970A1 11-aryl-benzo(b)naphtho(2,3-d)furans and 11-aryl-benzo(b)naphtho(2,3-d)thiophenes useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077969A1 Benzothiophenes, benzofurans, and indoles useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077968A1 Naphtho[2,3-b]heteroar-4-yl derivatives |
| 02/28/2001 | EP1077967A2 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077966A1 Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077965A1 Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077960A1 (2-acylaminothiazole-4-yl)acetic acid derivatives |
| 02/28/2001 | EP1077958A1 Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077957A1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
| 02/28/2001 | EP1077946A1 Fused tricyclic compounds which inhibit parp activity |
| 02/28/2001 | EP1077944A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity |
| 02/28/2001 | EP1077943A1 Heterocyclic inhibitors of p38 |
| 02/28/2001 | EP1077937A1 METHOD OF LOCKING 1$g(a)-OH OF VITAMIN D COMPOUNDS IN AXIAL ORIENTATION |
| 02/28/2001 | EP1077933A1 Substituted guanidines and diaminonitroethenes, their preparation and use |
| 02/28/2001 | EP1077929A1 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077928A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077927A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |